Two-signal requirement for growth-promoting function of yap in hepatocytes

eLife

Volumn 2015, Issue 4, 2015, Pages

  Su, Tian ^a   Bondar, Tanya ^a   Zhou, Xu ^a   Zhang, Cuiling ^a   He, Hang ^b   Medzhitov, Ruslan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; PEPTIDES AND PROTEINS; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; CARBON TETRACHLORIDE; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP PROTEIN, MOUSE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE FUNCTION; IMMUNOFLUORESCENCE MICROSCOPY; INFLAMMATION; LIVER CELL; LIVER INJURY; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICAL AND DRUG INDUCED LIVER INJURY; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; CARBON TETRACHLORIDE; CELL PROLIFERATION; CELLS, CULTURED; CHEMICAL AND DRUG INDUCED LIVER INJURY; GENE EXPRESSION PROFILING; HEPATOCYTES; INFLAMMATION; LIVER; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84922876333     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.02948     Document Type: Article

References (73)

1. Yu, F.X. & Guan, K.L. The Hippo pathway: regulators and regulations. Genes & development 27, 355-371 (2013).
2. Hong, W. & Guan, K.L. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Seminars in cell & developmental biology 23, 785-793 (2012).
3. Lin, J.I., Poon, C.L. & Harvey, K.F. The Hippo size control pathway--ever expanding. Science signaling 6, pe4 (2013).
4. Camargo, F.D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Current biology: CB 17, 2054-2060 (2007).
5. Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133 (2007).
6. Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes & development 22, 1962-1971 (2008).
7. Zhang, L. et al. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Developmental cell 14, 377-387 (2008).
8. Wu, S., Liu, Y., Zheng, Y., Dong, J. & Pan, D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Developmental cell 14, 388-398 (2008).
9. Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes & development 22, 1962-1971 (2008).
10. Reddy, B.V. & Irvine, K.D. Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Developmental cell 24, 459-471 (2013).
11. Yu, F.X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791 (2012).
12. Fan, R., Kim, N.G. & Gumbiner, B.M. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proceedings of the National Academy of Sciences of the United States of America 110, 2569-2574 (2013).
13. Bernascone, I. & Martin-Belmonte, F. Crossroads of Wnt and Hippo in epithelial tissues. Trends in cell biology 23, 380-389 (2013).
14. Attisano, L. & Wrana, J.L. Signal integration in TGF-beta, WNT, and Hippo pathways. F1000prime reports 5, 17 (2013).
15. Mullen, A.C. Hippo tips the TGF-beta scale in favor of pluripotency. Cell stem cell 14, 6-8 (2014).
16. Ferrigno, O. et al. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling. Oncogene 21, 4879-4884 (2002).
17. Beyer, T.A. et al. Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells. Cell reports 5, 1611-1624 (2013).
18. Konsavage, W.M., Jr. & Yochum, G.S. Intersection of Hippo/YAP and Wnt/beta-catenin signaling pathways. Acta biochimica et biophysica Sinica 45, 71-79 (2013).
19. Zaidi, S.K. et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. The EMBO journal 23, 790-799 (2004).
20. Shao, D. et al. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nature communications 5, 3315 (2014).
21. Strano, S. et al. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. The Journal of biological chemistry 276, 15164-15173 (2001).
22. Barry, E.R. & Camargo, F.D. The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Current opinion in cell biology 25, 247-253 (2013).
23. Shaw, R.L. et al. The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration. Development 137, 4147-4158 (2010).
24. Karpowicz, P., Perez, J. & Perrimon, N. The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development 137, 4135-4145 (2010).
25. Ren, F. et al. Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways. Proceedings of the National Academy of Sciences of the United States of America 107, 21064-21069 (2010).
26. Staley, B.K. & Irvine, K.D. Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation. Current biology: CB 20, 1580-1587 (2010).
27. Zhou, D. et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proceedings of the National Academy of Sciences of the United States of America 108, E1312-1320 (2011).
28. Barry, E.R. et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493, 106-110 (2013).
29. Cai, J. et al. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes & development 24, 2383-2388 (2010).
30. Zheng, T., Wang, J., Jiang, H. & Liu, L. Hippo signaling in oval cells and hepatocarcinogenesis. Cancer letters 302, 91-99 (2011).
31. Lu, L. et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proceedings of the National Academy of Sciences of the United States of America 107, 1437-1442 (2010).
32. Kowalik, M.A. et al. Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice. Hepatology 53, 2086-2096 (2011).
33. Lee, K.P. et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 107, 8248-8253 (2010).
34. Zhang, N. et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Developmental cell 19, 27-38 (2010).
35. Bai, H. et al. Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology 56, 1097-1107 (2012).
36. Yu, F.X., Meng, Z., Plouffe, S.W. & Guan, K.L. Hippo Pathway Regulation of Gastrointestinal Tissues. Annual review of physiology (2014).
37. Fernandez, L.A. et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes & development 23, 2729-2741 (2009).
38. Wang, K., Degerny, C., Xu, M. & Yang, X.J. YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochemistry and cell biology Biochimie et biologie cellulaire 87, 77-91 (2009).
39. Hahn, W.C. & Weinberg, R.A. Rules for making human tumor cells. The New England journal of medicine 347, 1593-1603 (2002).
40. Evan, G.I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128 (1992).
41. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. & Lowe, S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
42. O'Reilly, L.A., Huang, D.C. & Strasser, A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. The EMBO journal 15, 6979-6990 (1996).
43. Lapi, E. et al. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Molecular cell 32, 803-814 (2008).
44. Boggiano, J.C. & Fehon, R.G. Growth control by committee: intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. Developmental cell 22, 695-702 (2012).
45. Chen, C.L., Schroeder, M.C., Kango-Singh, M., Tao, C. & Halder, G. Tumor suppression by cell competition through regulation of the Hippo pathway. Proceedings of the National Academy of Sciences of the United States of America 109, 484-489 (2012).
46. Norman, M. et al. Loss of Scribble causes cell competition in mammalian cells. Journal of cell science 125, 59-66 (2012).
47. Schlegelmilch, K. et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144, 782-795 (2011).
48. Zhang, H., Pasolli, H.A. & Fuchs, E. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proceedings of the National Academy of Sciences of the United States of America 108, 2270-2275 (2011).
49. Bondar, T. & Medzhitov, R. p53-mediated hematopoietic stem and progenitor cell competition. Cell stem cell 6, 309-322 (2010).
50. Song, H. et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proceedings of the National Academy of Sciences of the United States of America 107, 1431-1436 (2010).
51. Huang da, W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4, 44-57 (2009).
52. Huang da, W., Sherman, B.T. & Lempicki, R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 37, 1-13 (2009).
53. Liu-Chittenden, Y. et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes & development 26, 1300-1305 (2012).
54. Consortium, E.P. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS biology 9, e1001046 (2011).
55. Anakk, S. et al. Bile acids activate YAP to promote liver carcinogenesis. Cell reports 5, 1060-1069 (2013).
56. Wang, C. et al. Differences in Yes-associated protein and mRNA levels in regenerating liver and hepatocellular carcinoma. Molecular medicine reports 5, 410-414 (2012).
57. Wu, H. et al. The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense. Cell reports 3, 1663-1677 (2013).
58. Weber, L.W., Boll, M. & Stampfl, A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Critical reviews in toxicology 33, 105-136 (2003).
59. Balani, S., Malik, R., Malik, R. & Kapoor, N. Cytomorphological variables of hepatic malignancies in fine needle aspiration smears with special reference to grading of hepatocellular carcinoma. Journal of cytology /Indian Academy of Cytologists 30, 116-120 (2013).
60. Chang, O. et al. The cytological characteristics of small cell change of dysplasia in small hepatic nodules. Oncology reports 23, 1229-1232 (2010).
61. Pan, J.B. et al. PaGenBase: a pattern gene database for the global and dynamic understanding of gene function. PloS one 8, e80747 (2013).
62. Yimlamai, D. et al. Hippo pathway activity influences liver cell fate. Cell 157, 1324-1338 (2014).
63. Wang, J. et al. TRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPalpha function. Molecular cell 51, 211-225 (2013).
64. Septer, S. et al. Yes-associated protein is involved in proliferation and differentiation during postnatal liver development. American journal of physiology. Gastrointestinal and liver physiology 302, G493-503 (2012).
65. Tomlinson, V. et al. JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell death & disease 1, e29 (2010).
66. Harrington, E.A., Bennett, M.R., Fanidi, A. & Evan, G.I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. The EMBO journal 13, 3286-3295 (1994).
67. Bleich, A. & Hansen, A.K. Time to include the gut microbiota in the hygienic standardisation of laboratory rodents. Comparative immunology, microbiology and infectious diseases 35, 81-92 (2012).
68. Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185 (2012).
69. Ben-Neriah, Y. & Karin, M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nature immunology 12, 715-723 (2011).
70. Pribluda, A. et al. A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer cell 24, 242-256 (2013).
71. Bondar, T. & Medzhitov, R. The origins of tumor-promoting inflammation. Cancer cell 24, 143-144 (2013).
72. Ito, Y. et al. Depression of liver-specific gene expression in regenerating rat liver: a putative cause for liver dysfunction after hepatectomy. The Journal of surgical research 51, 143-147 (1991).
73. Karolchik, D. et al. The UCSC Genome Browser database: 2014 update. Nucleic acids research 42, D764-770 (2014).